Can B Corp (CANB)

[skyhawk66]

Great Interview! CANB continues to make All the right moves 2022- And Beyond!
Loved this part;

Our second operating division is the hemp division," continued Alfonsi. "For Q3 we made some major acquisitions," he shared. "We increased our balance sheet assets to over $16 million as of 12-31-2021," said Alfonsi. "We're able to be vertically integrated from biomass and hemp crude thru to isolate, and a full line of retain CBD products and various isomers."

"With our Miami operation, we have modeled a consumption lounge adjacent to our lab production operations and hope to open similar operations in select cities ove the next several months. "Once opened in locations where State and Federal laws allow, you'll be able to purchase CBD, Delta-8, or Delta-10 products, and still have the ability to enjoy them in a lounge, which in the evening will turn into a nightclub with live entertainment," he shared, adding that "the lounge will also serve infused beverages and have that CBD Experience being located adjacent to an actual production lab".

"Our third operating division is Duramed, which is our medical device company," said Alfonsi, before elaborating on the Company's wearable technology. "We are now in Michigan, where we have doubled our business," he shared, adding that the Company is also doing business in New York.

Jolly then commented on the Company's recently announced partnerships with PrimeX and American Development Partners. "In March, we signed the Brazilian Joint Venture with PrimeX," said Alfonsi, adding that CBD was not legal in Brazil until recently. "We have final products that are ready to be shipped to Brazil, and hopefully local physicians will be writing scripts on behalf of our products for their patients."

"With American Development Partners, it is a new concept for us," continued Alfonsi. "We were able to secure the American Development Partners to create and raise up to $200 million to build as many as 50 consumption lounges that are available to be assigned to our labs."

"What kind of new isomers are scheduled to be released within the next few months?" asked Jolly. "Right now we are able to do Delta-8," explained Alfonsi. "CBD is still a very low price, but once you convert that isolate into an isomer the price jumps," he explained, before elaborating on the different isomers. "We've been able to increase our revenues and margins for the simple reason that we are able to create these isomers."

To close the interview, Alfonsi elaborated on the Company's significant growth, and encouraged listeners and shareholders to keep up-to-date on their current plans and projects.

To hear Marco Alfonsi's entire interview, follow the link to the podcast here: https://audioboom.com/posts/8069795-can-b-corp-discusses-2022-growth-opportunities-and-new-partnerships-on-the-stock-day-podcast.